CHATSWORTH, CA, Oct. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Cavitation Technologies, Inc. ("CTi" or the "Company") (OTCQB:CVAT), a leading ESG company, which designs and manufactures innovative flow-through nano-technology systems for fluid processing applications worldwide, is pleased to announce a major technological breakthrough with the successful development of a cutting-edge Plasma-Based Cavitation system (www.HydroPlasma.Tech) designed for water purification and advanced oxidation. Now, the company is moving forward with building its first pilot system and implementing commercial trials.

Globally, over 80% of all the wastewater from our homes, cities, industry and agriculture flows back to nature without being treated or reused – polluting the environment and losing valuable nutrients and other recoverable materials (UN research). Meanwhile, according to Stratview Research, The Cold Plasma Market is estimated to grow from US$ 1.5 Billion in 2021 to US$ 3.1 Billion by 2027 at a CAGR of 12.5% during the forecast period of 2022-2027, which gives us a big opportunity to work with global water challenges.

Cavitation plasma reactor combines cavitation with cold, non-equilibrium discharge generated by plasma to produce reactive agents such as hydroxyl radicals (OH) and hydrogen peroxide (H2O2). These agents are highly efficient at breaking down both organic and inorganic compounds, including bacteria and viruses.

(Flow-through process)
CTi’s innovative system is highly scalable, ranging from 2 gallons per minute (GPM) to 40 GPM, making it adaptable for a wide range of applications. By harnessing the power of cold, non-equilibrium discharge generated by plasma, CTi’s technology can be effectively implemented in various contexts, including:

• Agriculture
• Textile wastewaters
• High precision electronics
• Water remediation in wineries 
• Purified water consumption

All these sources are characterized by high levels of COD (Chemical Oxygen Demand) and complex mixtures of constituents. For example, our technology extends its impact to the agricultural ecosystem by enhancing crop growth through the control of microorganism development, thus accelerating vegetative and root growth, resulting in increased plant height, more robust seedlings, and greater biomass. Furthermore, the shelf-life of harvested fruits and vegetables may be extended by irrigating the crops with Hydro-Plasma Water.

Roman Gordon, Global Technology Manager and Founder of Cavitation Technologies, Inc., commented: “CTi's breakthrough technology not only addresses pressing global challenges but also presents significant opportunities for our company. We are committed to developing and implementing this technology to benefit communities, industries, and agriculture, providing clean and safe water while promoting sustainable growth. 

“Several customers have expressed interest in commencing a commercial trial of the system technology. As a result, the first commercial prototype is expected to be fully completed by the end of this year.”

About Cavitation Technologies, Inc.
Founded in 2007, the company designs and manufactures innovative flow-through devices and systems, as well as develops processing technologies for use in edible oil refining, renewable fuel production, water treatment, and alcoholic beverage enhancement. The company's patented Nano Reactor® systems and various technologies have over 40 patents issued and filed both domestically and abroad.

Follow us on Twitter for real time updates: https://twitter.com/CavitationTech

Like us on Facebook to receive live feed updates: https://www.facebook.com/ctinanotech

Forward-Looking Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by terminology such as ''may,'' ''should,'' ''potential,'' ''continue,'' ''expects,'' ''anticipates”, ''intends,'' ''plans,'' ''believes,'' ''estimates,'' and similar expressions, such as, “As a result, the first commercial prototype is expected to be fully completed by the end of this year”. These forward-looking statements are based largely on the Company's expectations and are subject to a number of risks and uncertainties, certain of which are beyond the Company's control. Actual results could differ materially from these forward-looking statements as a result of a variety of factors including, among others, our ability to perform the installation as anticipated, the state of the economy, the competitive environment and other factors described in our most recent Form 10-K and our other filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. In light of these risks and uncertainties there can be no assurances that the forward-looking statements contained in this press release will in fact transpire or prove to be accurate. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

Cavitation Technologies, Inc.
8187180905
This email address is being protected from spambots. You need JavaScript enabled to view it.